NCT03737708View on ClinicalTrials.gov

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 13, 2019

Primary Completion Date

June 16, 2020

Study Completion Date

June 16, 2020

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG

tacrolimus

Administered orally

DRUG

methotrexate

Administered orally

BIOLOGICAL

adalimumab

Administered as subcutaneous injection

BIOLOGICAL

tocilizumab

Administered by intravenous injection

BIOLOGICAL

abatacept

Administered by intravenous injection

Trial Locations (10)

Unknown

Site KR82003, Daegu

Site KR82007, Daegu

Site KR82006, Daejeon

Site KR82002, Incheon

Site KR82009, Seongnam

Site KR82001, Seoul

Site KR82005, Seoul

Site KR82010, Seoul

Site KR82012, Seoul

Site KR82013, Suwon

All Listed Sponsors

lead

Astellas Pharma Korea, Inc.

INDUSTRY

NCT03737708 - A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA) | Biotech Hunter | Biotech Hunter